DK1001978T3 - Angiotensinderivater - Google Patents

Angiotensinderivater

Info

Publication number
DK1001978T3
DK1001978T3 DK98930927T DK98930927T DK1001978T3 DK 1001978 T3 DK1001978 T3 DK 1001978T3 DK 98930927 T DK98930927 T DK 98930927T DK 98930927 T DK98930927 T DK 98930927T DK 1001978 T3 DK1001978 T3 DK 1001978T3
Authority
DK
Denmark
Prior art keywords
angiotensin
derivatives
angiotensin derivatives
Prior art date
Application number
DK98930927T
Other languages
English (en)
Inventor
James Francis Glover
Arthur Rushton
Stephen Clinton Young
Phillip John Morgan
Original Assignee
Proteus Molecular Design
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9713361.5A external-priority patent/GB9713361D0/en
Priority claimed from GB9808696A external-priority patent/GB9808696D0/en
Application filed by Proteus Molecular Design filed Critical Proteus Molecular Design
Application granted granted Critical
Publication of DK1001978T3 publication Critical patent/DK1001978T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
DK98930927T 1997-06-24 1998-06-23 Angiotensinderivater DK1001978T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9713361.5A GB9713361D0 (en) 1997-06-24 1997-06-24 Peptide derivatives
GB9808696A GB9808696D0 (en) 1998-04-23 1998-04-23 Peptide derivatives
EP98930927A EP1001978B1 (en) 1997-06-24 1998-06-23 Angiotensin derivatives
PCT/GB1998/001833 WO1998058952A1 (en) 1997-06-24 1998-06-23 Angiotensin derivatives

Publications (1)

Publication Number Publication Date
DK1001978T3 true DK1001978T3 (da) 2005-08-01

Family

ID=26311786

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98930927T DK1001978T3 (da) 1997-06-24 1998-06-23 Angiotensinderivater

Country Status (13)

Country Link
US (1) US20090105150A1 (da)
EP (2) EP1001978B1 (da)
JP (1) JP4850321B2 (da)
AR (1) AR014884A1 (da)
AT (1) ATE292143T1 (da)
AU (1) AU748903B2 (da)
CA (1) CA2294996C (da)
DE (1) DE69829567T2 (da)
DK (1) DK1001978T3 (da)
ES (1) ES2241147T3 (da)
NZ (1) NZ501832A (da)
PT (1) PT1001978E (da)
WO (1) WO1998058952A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902888B1 (en) 1999-05-21 2005-06-07 Myriad Genetics, Inc. Diabetes gene
WO2000071751A1 (en) * 1999-05-21 2000-11-30 Myriad Genetics, Inc. Diabetes gene
WO2003031466A2 (en) * 2001-10-05 2003-04-17 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
MXPA04002644A (es) 2001-10-05 2004-07-08 Cytos Biotechnology Ag Conjugados que portan un peptido de angiotensina y usos de los mismos.
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
CN114957400B (zh) * 2022-06-10 2024-02-23 郑州伊美诺生物技术有限公司 人工修饰的血管紧张素ii及血管紧张素ⅱ酶标记物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US4388995A (en) * 1981-06-08 1983-06-21 Ahn Min H Collapsible container
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
CA1304886C (en) * 1986-07-10 1992-07-07 Heinz Dobeli Metal chelate resins
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
FR2664386B1 (fr) * 1990-07-05 1992-10-23 Sanofi Sa Trousse pour le dosage specifique de l'angiotensine ii.
US5171662A (en) * 1990-09-13 1992-12-15 The Upjohn Company Method of detecting HIV protease activity
AU665599B2 (en) * 1991-11-08 1996-01-11 Hemosol Inc. Hemoglobins as drug delivery agents

Also Published As

Publication number Publication date
AR014884A1 (es) 2001-04-11
EP1001978B1 (en) 2005-03-30
NZ501832A (en) 2002-12-20
EP1486505A1 (en) 2004-12-15
EP1001978A1 (en) 2000-05-24
CA2294996A1 (en) 1998-12-30
ES2241147T3 (es) 2005-10-16
JP4850321B2 (ja) 2012-01-11
DE69829567T2 (de) 2006-02-16
CA2294996C (en) 2009-12-15
ATE292143T1 (de) 2005-04-15
AU748903B2 (en) 2002-06-13
AU8120398A (en) 1999-01-04
PT1001978E (pt) 2005-08-31
WO1998058952A1 (en) 1998-12-30
JP2002507886A (ja) 2002-03-12
DE69829567D1 (de) 2005-05-04
US20090105150A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
DK1005446T3 (da) N-aroylphenylalaninderivater
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
ATE250583T1 (de) Substituierte 3-cyanochinoline
PT994890E (pt) Derivados de benzimidazole
PT915088E (pt) Derivados de d-prolina
ATE255098T1 (de) Substituierte chromanderivate
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
ATE440854T1 (de) 5-deoxy-cytidin-derivate
ATE255099T1 (de) Substituierte chromanderivate
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495L (no) Fenoksymetylpiperidin-derivater
DK1001978T3 (da) Angiotensinderivater
DK0966437T3 (da) 5-Aroylnaphthalenderivater
ATE244705T1 (de) Substituierte 4-benzoyl-pyrazole
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
DE59807877D1 (de) Substituierte 4-benzoyl-pyrazole
FI974129A (fi) Apuväline
DE59810960D1 (de) Substituierte phenyluracile
SE9702610D0 (sv) Klamma
SE9700194D0 (sv) Hjälpmedel